Schizophrenia News and Research

Latest Schizophrenia News and Research

Scientists identify important molecular signal that guides development of brain

Scientists at The Scripps Research Institute (TSRI) have decoded an important molecular signal that guides the development of a key region of the brain known as the neocortex.

8 Aug 2013

Researchers identify specific genetic mutations that contribute to disorders of brain development

A collaborative team of researchers including scientists from UCLA has uncovered evidence that a specific genetic alteration appears to contribute to disorders of brain development, including schizophrenia. They also found that schizophrenia shares a common biological pathway with Fragile X mental retardation syndrome, a disorder associated with both intellectual impairment and autism.

7 Aug 2013

Targacept reports net loss of $12.4 million for Q2 2013

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today reported its financial results for the second quarter and six months ended June 30, 2013.

6 Aug 2013

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

BioLineRx, a biopharmaceutical development company, announced today that BL-8040 has been shown in pre-clinical trials to be effective for the treatment of thrombocytopenia, or reduced platelet production.

5 Aug 2013

Disruption to TOP3B gene increases susceptibility to schizophrenia and a learning disorder

A team of researchers have shown that schizophrenia and a disorder associated with autism and learning difficulties share a common biological pathway. This is one of the first times that researchers have uncovered genetic evidence for the underlying causes of schizophrenia.

5 Aug 2013

Research roundup: Making sense (or not) of health insurance; what a full Medicaid expansion could look like; recession and coverage

Each week, KHN reporter Alvin Tran compiles a selection of recently released health policy studies and briefs.

3 Aug 2013

Study proposes novel approach for understanding how genome affects biology of the human body

Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient’s genetic profile –also known as personalized medicine – we need to know how this genetic variant affects health.

1 Aug 2013

Montreal scientists develop novel approach for scanning entire genome

Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.

1 Aug 2013

Study: Full Body Illusions can be accompanied by changes in body temperature

Researchers from the Center for Neuroprosthetics at the Swiss Federal Institute of Technology (EPFL), Switzerland, show that people can be "tricked" into feeling that an image of a human figure -- an "avatar" -- is their own body. The study is published in the open-access journal Frontiers in Behavioral Neuroscience.

31 Jul 2013

Naurex receives new U.S. patent for its lead compound, GLYX-13

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced issuance of a new U.S. patent for its lead compound, GLYX-13.

31 Jul 2013

Researcher discovers potential explanation for shizophrenia symptoms

By observing the eye movements of schizophrenia patients while playing a simple video game, a University of British Columbia researcher has discovered a potential explanation for some of their symptoms, including difficulty with everyday tasks.

29 Jul 2013

Some warn of 'overwhelming' mental illness care cost without new research investment

Scientists warn health systems could face "overwhelming" costs of treating mental illness if no new money is invested in research.

26 Jul 2013

First Edition: July 25, 2013

Today's headlines include reports about WellPoint's second-quarter profits and the Insitute of Medicine's findings about geographic varitions in Medicare spending.

25 Jul 2013

Research finds potential long-term effects of marijuana use in adolescence

Regular marijuana use in adolescence, but not adulthood, may permanently impair brain function and cognition, and may increase the risk of developing serious psychiatric disorders such as schizophrenia, according to a recent study from the University of Maryland School of Medicine.

25 Jul 2013

International Consortium receives grant to examine genetic reasons of schizophrenia in deletion syndrome patients

Today, the Royal College of Surgeons in Ireland (RCSI) will host a two day International Brain and Behaviour Consortium meeting on Chromosome 22q11.2 Deletion Syndrome (22q11.2DS).

24 Jul 2013

Researchers identify neural pathways involved in word learning among humans

For the first time scientists have identified how a pathway in the brain which is unique to humans allows us to learn new words. The average adult's vocabulary consists of about 30,000 words. This ability seems unique to humans as even the species closest to us -- chimps -- manage to learn no more than 100.

23 Jul 2013

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Researchers from the University of York have demonstrated that the change in cannabis declassification in 2009 has coincided with a significant increase in hospital admissions for cannabis psychosis - rather than the decrease it was intended to produce.

19 Jul 2013

Long-term cannabis use, dopamine and motivation: an interview with Dr Michael Bloomfield, Department of Medicine at Imperial

We classified ‘long-term’ cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that’s used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.

17 Jul 2013

Brain mechanism could explain how we hear inner voice in absence of actual sound

Whether you're reading the paper or thinking through your schedule for the day, chances are that you're hearing yourself speak even if you're not saying words out loud. This internal speech - the monologue you "hear" inside your head - is a ubiquitous but largely unexamined phenomenon.

17 Jul 2013

Study identifies new therapeutic targets for Huntington's disease

A scientific study describes that GluN3A subunits of NMDA receptors that interact with glutamate —the main exciting neurotransmitter in the nervous system— are therapeutic targets against Huntington's disease.

16 Jul 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Scientists identify important molecular signal that guides development of brain

Researchers identify specific genetic mutations that contribute to disorders of brain development

Targacept reports net loss of $12.4 million for Q2 2013

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

Disruption to TOP3B gene increases susceptibility to schizophrenia and a learning disorder

Research roundup: Making sense (or not) of health insurance; what a full Medicaid expansion could look like; recession and coverage

Study proposes novel approach for understanding how genome affects biology of the human body

Montreal scientists develop novel approach for scanning entire genome

Study: Full Body Illusions can be accompanied by changes in body temperature

Naurex receives new U.S. patent for its lead compound, GLYX-13

Researcher discovers potential explanation for shizophrenia symptoms

Some warn of 'overwhelming' mental illness care cost without new research investment

First Edition: July 25, 2013

Research finds potential long-term effects of marijuana use in adolescence

International Consortium receives grant to examine genetic reasons of schizophrenia in deletion syndrome patients

Researchers identify neural pathways involved in word learning among humans

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Long-term cannabis use, dopamine and motivation: an interview with Dr Michael Bloomfield, Department of Medicine at Imperial

Brain mechanism could explain how we hear inner voice in absence of actual sound

Study identifies new therapeutic targets for Huntington's disease

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in